Association between antibacterial drugs and colorectal cancer risk
Some studies have suggested that long-term use of antimicrobial drugs may disrupt the intestinal microbiota, leading to changes in the bacterial community and thus increasing the risk of colorectal cancer. However, the results are inconsistent across studies and may be related to differences in study design, sample size, and patient populations. Few population-based studies have prospectively assessed the risk of exposure to colorectal adenomas with colorectal cancer, and many retrospective case-control studies have methodological challenges related to selection and recall bias. The use of PLCO cancer screening data to prospectively assess the association between antimicrobial use in prescription medications and colorectal cancer risk informs clinical practice.
The aim was to investigate the relationship between self-reported antimicrobial use in prescription drugs and the risk of colorectal cancer in the PLCO cohort, to deepen understanding of the relationship between antimicrobial use and colorectal cancer risk, to inform clinical practice, and to provide insight and direction for further research to enhance understanding of colorectal cancer treatment and improve treatment outcomes.
Name :Xi-Da Chen, institution : Chongqing Medical University